Autopsy of COVID-19 Patients in China
Xiu-Wu Bian,Xiao-Hong Yao,Yi-Fang Ping,Shicang Yu,Yu Shi,Tao Luo,Zhi-Cheng He,Rui Tang,Cong Chen,Wen-Juan Fu,Hongyan Zhang,Hua-Rong Zhang,Dong-Fang Xiang,Qing-Rui Li,Xuequan Huang,Tingyuan Li,Pengnan Zhao,Chaofu Wang,Xiaochun Fei,Jun Cai,Lei Zhao,Heng Zhang,Zhenghua Liu,Liang Liu,Guoping Wang,Xiu Nie,Yiwu Zhou,Liang Ren,Qian Liu,Yi Wang,Qilin Ao,Xi Wang,Yaqi Duan,Jiansha Li,Jin Xiong,Sanpeng Xu,Jie Zhang,Sizhe Huang,Ming Yang,Bo Huang,Xiang Li,Lixu Peng,Pan Xi,Xiong Hua,Hua Su,Sihua Wangcheng,Cheng Yu,Haibo Wu,Heng Li,Yong Ren,Xinwei Chen,Liwei Liang,Zongxing Zhang,Rong Chen,Fei Deng,Guoqiang Qu,Rongshuai Wang,Yunyun Wang,Xiaowei Zhou,Fusheng Wang,Jingmin Zhao
DOI: https://doi.org/10.1093/nsr/nwaa123
2020-01-01
Abstract:Distribution of SARS-CoV-2 virus and pathological features of multiple organs in COVID-19 patients remains unclear, which interferes with the improvement of COVID-19 diagnosis and treatment In this article, we summarize the pathological findings obtained from systematic autopsy (37 cases) and percutaneous multiple organ biopsy (“minimally invasive autopsy”, 54 cases) These findings should shed light on better understanding of the progression of COVID-19 infection and the means of more effective intervention